期刊文献+

抗菌肽PR-39真核表达载体的构建及表达检测 被引量:4

Construction of eukaryotic expression vector encoding antimicrobial peptides PR-39 and its expression in 293T cell
下载PDF
导出
摘要 目的:构建富含脯氨酸精氨酸的39位氨基酸抗菌肽(Proline-arginine rich 39-amino acid peptide,PR-39)的真核表达载体,并检测它在293T细胞中的表达情况。方法:以含有PR-39核心编码区(Core coding regions,CDS)序列的质粒pBluescriptⅡSK-PR-39为模板,PCR扩增PR-39CDS序列并测序。扩增片段插入真核表达质粒pGC-FU中,构建包含PR-39基因的重组表达质粒pGC-FU-PR-39。阳性克隆用限制性内切酶酶切及测序鉴定后用脂质体2000转染293T细胞,荧光显像观察其转染效率,Western blot检测目的蛋白表达情况。结果:成功扩增出PR-39基因,通过酶切测序鉴定证明成功构建了包含PR-39的真核表达载体pGC-FU-PR-39,转化293T细胞24h后观察到荧光,Western blot检测到目的蛋白。结论:本实验成功构建PR-39真核表达载体,并能在293T细胞中表达PR-39-GFP融合蛋白,这为进一步研究PR-39的作用奠定了基础。 Objective: To construct eukaryotic plasmid expressing PR-39 and test whether the plasmid can be expressed in the 293 T cell. Methods:The core coding regions (CDS) sequence of PR-39 was amplified by PCR from pBluescript II SK-PR-39.Then the PR-39 gene was inserted into the eukaryotic expression plasmid pGC-FU. The resultant recombinant plasmid was confirmed by restriction enzyme cutting and sequencing, and then was designated as pGC-FU-PR-39. The recombinant plasmid pGC-FU-PR-39 was transfected into 293 T cell by Lipofectamine 2000. Transfected efficiency was observed by fluorographic unit, Western blot was used to certify whether the purpose protein was correctly expressed in 293 T cell. Results:The CDS sequence of PR-39 was correctly amplified. The recombinant plasmid was successfully constructed and could be correctly expressed in 293 T cell. Conclusion:We successfully constructed PR-39 eukaryotic expression plasmid and observed the expression of PR-39-GFP fusion protein. It lays a foundation for further studies of PR-39.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2009年第12期1643-1645,共3页 Journal of Chongqing Medical University
基金 重庆市科委自然科学基金(编号:2008BB5213)
关键词 抗菌肽 PR-39 真核表达载体 Antimicrobial peptide PR-39 Eukaryotic expression
  • 相关文献

参考文献13

  • 1Gennam R, Zanetti M, Beaincsa M, et al. Pro-rich anti icrobial petides from animals structure, biological functions and mechanism of action[J]. Curr Pham Des, 2002,8(9) :763-778.
  • 2Delfino D, Cusumano V V, Tomasello F, et al. Beneficial effects of antibacterial peptide PR-39 in a neonatal murine model of endotoxic shock[J]. New Microbiol, 2004,27 ( 4 ) : 369-374.
  • 3Li W F, Ma G X, Zhou X X, et at. Apidaecin-type peptides:hiodiversity, structure-function relationships and mode of action[J]. Peptides, 2006,27 (9) : 2350-2359.
  • 4Wu J,Parungo C,Wu G,et al. PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2[J].Circulation, 2004,109( 13 ) : 1660-1667.
  • 5Broqden K A,Ackermann M,Mccray P B,et al.Antimicrobial peptides in animals and their role in host defences[J]. Int J Antimicrob Agents, 2003,22(5 ): 465-478.
  • 6Vunnam S, Juvvadi P, Memifield R B, et al. Synthesis and antibacterial action of cecropin and proline-arginine-rich peptides from pig intestine[J]. J Pept Res, 1997,49( 1 ) :59-66.
  • 7Linde C M, Hoffner S E, Refai E, et al. In vitro activity of PR-39,a proline- arginine-rich peptide,against susceptible and muhi-drug-resistant Mycobacterium tuberculosis[J]. J Anlimicrob Chemother, 2001,47(5 ):575-580.
  • 8Boman H G,Agerberth B, Boman A,et al. Mechanisms of action on Escherichia coli of cecropin-PI and PR-39,two antibacterial peptides from pig intestine [J]. Infect Immun, 1993,61 ( 7 ) : 2978-2984.
  • 9Boman H G.Antibacterial peptides:basic facts and emerging concepts [J]. Journal of Internal Medicine, 2003,254(3) : 197-215.
  • 10Djanani A, Mosheimer B, Kaneider N C, et el. Heparan sulfate proteogtycan- dependent neutrophil chemotaxis toward PR-39 cathelicidin[J]. J Inflamm (Lond), 2006,3( 1 ) : 14.

二级参考文献8

  • 1伊正君,朱道银,李俊明,何永林,杨健,李娜.人颗粒溶素与EGFP基因融合表达载体的构建及其在鼠巨噬细胞RAW264.7中的表达[J].第四军医大学学报,2005,26(23):2125-2128. 被引量:3
  • 2Leemans J C, Thepen T, Weijer S,et al. Macrophages play a dual role during pulmonary tuberculosis in mice [ J]. J Infect Dis, 2005, 191 (1): 65-74.
  • 3Gennaro R, Zanetti M, Beaincasa M, et al. Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action[J]. Curr Pharm Des, 2002, 8(9) : 763 -778.
  • 4Jenssen H, Hamill P, Hancock R E. Peptide antimicrobial agents[ J]. Clin Microbiol Rev, 2006, 19(3) : 491 -511.
  • 5Wu J, Parungo C, Wu G, et al. PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2[ J]. Circulation, 2004, 109(13): 1660-1667.
  • 6Lee P H, Ohtake T, Zaiou M, et al. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection [J]. Proc Natl Acad Sci U S A, 2005, 102(10) : 3750 -3755.
  • 7Yi Z, Fu Y, Yang C, et al. Recombinant M. smegmatis vaccine targeted delivering IL12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice [ J ]. Vaccine, 2007, 25(4) : 638 -648.
  • 8罗家琴,李富祥,张以芳.抗胞内菌感染免疫及其治疗[J].微生物学杂志,2004,24(2):46-49. 被引量:9

共引文献5

同被引文献59

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部